SOME RELATED FACTORS TO COMMON ADVERSE EVENTS AFTER THE 3rd DOSE OF VACCINE AGAINST COVID-19 AMONG PEOPLE VACCINATED AT THE VACCINATION SITE OF HANOI MEDICAL UNIVERSITY 2022
Main Article Content
Abstract
Objectives: to analyze some factors related to common reactions after Vaccination with 3rd doses of COVID-19 Vaccine among people Vaccinated at the Vaccination site of Hanoi Medical UniVersity in 2022. Methods: a cross-sectional description was performed on 721 study subjects during the period from January 2022 to October 2023. Results: the reaction rate after the 3rd injection was 60.9%, in which the reaction rate after the additional dose was 57.8%, and after the booster dose was 64.0%, the difference is not statistically significant (p>0.05). Post-injection reactions were more common in younger age groups, certain occupational groups, groups with a history of reactions following preVious injections, and groups with a history of chronic disease in booster dose subjects (p< 0.05). Gender, history of allergy, allergic disease, and type of Vaccine receiVed at the primary dose were not statistically significant with the response rate after after 3rd doses of Comirnaty Vaccine (Pfizer). Conclusion: the factors of age group, occupation, medical history in young people receiVing booster dose and history of allergy to preVious injections are significantly related to the reaction after 3rd doses of COVID-19 Vaccine, additional dose and booster dose, so it is important to carefully take the history in screening before deciding to Vaccinate.
Article Details
Keywords
common adVerse eVents, Vaccine against COVD-19, related factors.
References
2. Interim statement on booster doses for COVID-19 vaccination. Accessed May 16, 2023. https://www.who.int/news/item/04-10- 2021-interim-statement-on-booster-doses-for- coVid-19-Vaccination
3. Bộ Y tế. CÔng văn 10225/BYT-DP 2021 tiêm Vắc xin phòng COVID19 liều cơ bản Và nhắc lại. Published online 2021.
4. Bộ Y tế. CÔng văn 10722/BYT-DP 2021 tiêm Vắc xin
phòng COVID19 liều cơ bản. Published online 2021.
5. Mukesh Agrawal và Niranjan Shendurnikar (2005). Immunization for children. Published online 2005.
6. Hause AM, Baggs J, Marquez P, et al. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022. Morb Mortal Wkly Rep. 2022;71(7):249-254. doi:10.15585/mmwr.mm7107e1
7. Jeon M, Kim J, Oh CE, Lee JY. AdVerse EVents Following Immunization Associated with CoronaVirus Disease 2019 Vaccination Reported in the Mobile Vaccine AdVerse EVents Reporting System. J Korean Med Sci. 2021;36(17):e114. doi:10.3346/jkms.2021.36.e114
8. Tran VN, Nguyen HA, Le TTA, Truong TT, Nguyen PT, Nguyen TTH. Factors influencing adVerse eVents following immunization with AZD1222 in Vietnamese adults during first half of 2021. Vaccine. 2021;39(44):6485-6491. doi:10.1016/j.Vaccine.2021.09.060
9. Hause AM, Baggs J, Gee J, et al. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70 (39):1379-1384. doi:10.15585/mmwr.mm7039e4
10. Chapin-Bardales J, Gee J, Myers T. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. JAMA. 2021;325(21):2201- 2202. doi:10.1001/jama.2021.5374